European Medicines Agency Myocarditis Workshop Report (January 2023)

In January 2023, the European Medicines Agency (EMA) hosted a workshop on myocarditis post-COVID vaccination. This workshop reviewed the current understanding of the epidemiology, clinical manifestation, and pathophysiology of myocarditis after mRNA COVID vaccination (Spikevax and Comirnaty) or Nuvaxovid, a protein based-vaccine.

Click here to view the official summary and relevant documents.

Close Menu